采血过程中肝素与枸橼酸添加剂的携带污染
该研究通过模拟标准化静脉采血评估枸橼酸和肝素添加剂的携带污染风险,发现标准化采血时污染极不可能发生,但偏离采血指南时较小体积即可严重改变凝血和临床化学检测结果。
要点
- 标准化采血时肝素或枸橼酸污染风险极低。
- 偏离采血指南时小体积污染即可严重干扰凝血检测。
- 离子钙对枸橼酸污染最敏感,阈值体积最小。
核心结论
- 标准化静脉采血时肝素或枸橼酸污染极不可能发生,但偏离采血指南时较小污染体积即可严重改变检测结果。
研究设计与样本
- 模拟标准化静脉采血,以钠和锂为替代标志物量化蒸馏水中枸橼酸和肝素携带污染风险;并研究不同体积枸橼酸血或纯枸橼酸污染肝素血对电解质和钙磷测定的影响,以及不同体积肝素血污染枸橼酸血对肝素抗Xa活性、锂、APTT、PT和TT的影响。
主要发现
- 标准化采血模拟中替代标志物浓度无显著差异。
- 肝素血样本被枸橼酸血污染超过5-50 μL时离子钙出现临床显著改变,超过100-1000 μL时钠、氯和总钙出现临床显著改变。
- 纯枸橼酸携带污染在略低体积时出现类似结果。
- 肝素血携带污染在超过5-100 μL时对凝血检测产生临床显著干扰。
临床怎么用
- 应遵循采血指南以最大限度降低添加剂携带污染风险。
- 偏离采血指南时需警惕小体积污染对凝血和临床化学检测的严重干扰。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background Published evidence on the risk of additive carryover during phlebotomy remains elusive. We aimed to assess potential carryover of citrated and heparinized blood and the relative volume needed to bias clinical chemistry and coagulation tests. Methods We simulated standardized phlebotomies to quantify the risk of carryover of citrate and heparin additives in distilled water, using sodium and lithium as surrogates. We also investigated the effects of contamination of heparinized blood samples with increasing volumes of citrated blood and pure citrate on measurements of sodium, potassium, chloride, magnesium, total and ionized calcium and phosphate. Likewise, we studied the effects of contamination of citrated blood samples with increasing volumes of heparinized blood on heparin (anti-Xa) activity, lithium, activated partial thromboplastin time (APTT), prothrombin time (PT) and thrombin time (TT). We interpreted these results based on measurement deviations beyond analytical, biological and clinical significance. Results Standardized phlebotomy simulations revealed no significant differences in concentration of surrogate markers. Clinically significant alterations were observed after contamination of heparinized blood samples with volumes of citrated blood beyond 5-50 μL for ionized calcium and beyond 100-1000 μL for sodium, chloride and total calcium. Investigations of pure citrate carryover revealed similar results at somewhat lower volumes. Heparinized blood carryover showed clinically significant interference of coagulation testing at volumes beyond 5-100 μL. Conclusions Our results suggest that during a standardized phlebotomy, heparin or citrate contamination is highly unlikely. However, smaller volumes are sufficient to severely alter test results when deviating from phlebotomy guidelines.
引用
- Keppel MH, Auer S, Lippi G, et al. Heparin and citrate additive carryover during blood collection. Clin Chem Lab Med. 2019. PMID: 31377734. doi:10.1515/cclm-2019-0433
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。